The FDA has just released the first wave of their Electronic Cigarette, Tobacco study, and the results do look promising for the vaping community.

A conference held by the Society for Research on Nicotine and Tobacco included presentations from numerous organizations. The most interesting presentation was from the U.S. Food and Drug Administration (FDA) and National Institute of Health’s Population Assessment of Tobacco and Health (PATH). They shared their results for the first wave of their study on electronic cigarettes and tobacco.

PATH is a long-term study, mandated in 2011, to help the FDA gain better understanding of tobacco use. This study consists of about 46,000 U.S. tobacco and non-tobacco users, all above the age of 12. The first wave of this study started in 2013, and the results were presented at the conference last week.

“E-cigs were a big topic in the PATH study, along with many other presentations, as the regulatory and scientific communities try to get a better grasp of the implications from this innovation,” stated Vivien Azer, a tobacco analyst with the Cowen Group.

The data happened to help dispute the claims that electronic cigarettes were a gateway to other tobacco products. A majority of the electronic cigarette users in this study were already consumers of other tobacco products before they started using e-cigarettes.

You can read the results from the study by clicking here!

While the results from the first wave of the study look promising, the most interesting part of the FDA’s study is the fact that their final wave will not be completed until 2022. PATH researchers announced last week that their study will be extended for four years and will include seven waves.

“We view the extension of the study as a positive (given the agency will take time to evaluate findings from the study and could potentially push back any incremental regulations),” Azer said.

Any positive studies regarding electronic cigarettes by the FDA are a positive for this industry. We can’t forget that the FDA’s deeming regulations are still pending, BUT with this extensive study that the FDA and PATH is working on, it is the best news that we’ve heard from the FDA in a long time.

Please don’t forget that this is not at all guaranteed and we still need to stand up for our right to vape. There are some extremely prohibitive regulations pending in California right now, and there are large number of other pending measures that could lead to major regulations in this industry.

Are you one of the 119,000 vapers that are committed to help fight for our right to vape? If not, it only takes about 15 seconds to join CASAA and it is 100% free.

Join CASAA Today

What do you think about the FDA and PATH’s study? Do you think this is good for the vaping industry? Let us know in the comments below, we love to hear from our fellow vapers!